drugset / Trial / NCT02820298

Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects

NCT02820298

Phase 1 Completed 25 enrolled Theracos
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study was to investigate the effect of a high-fat meal on the levels of bexagliflozin in the blood in healthy subjects.

Timeline

Start
2016-06-20
Primary completion
2016-08-29
Completion
2016-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Bexagliflozin Small molecule 20 mg Oral